Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2010
12/01/2010CN101007013B Liposome of astragaloside IV and its medicinal preparation
11/2010
11/30/2010US7842698 Autoimmune diseases; antiinflamamtory agents, cardiovascular disorders; neurodegenerative diseases, kidney diseases, anticancer agents; platelet aggregation
11/30/2010US7842684 Diphenylazetidinone derivatives possessing cholesterol absorption inhibitor activity
11/30/2010US7842677 use in the field of neuroprotection and cancer treatment (neuroblastoma tumors)
11/30/2010US7842283 use in sclerotherapy of blood vessels; from a device, injecting a mixture of blood dispersible gases carbon dioxide and/or oxygen, and a sclerosing agent polidocanol, foaming in blood veins; avoiding use of potentially hazardous amounts of nitrogen; treating varicose veins disorder; drug delivery device
11/30/2010US7842282 use in sclerotherapy of blood vessels; from medical device, injecting a mixture of blood dispersible gases carbon dioxide and/or oxygen, and a sclerosing agent polidocanol, foaming in blood veins; avoiding use of potentially hazardous amounts of nitrogen; treating varicose veins disorder; drug delivery
11/30/2010CA2482858C Tricyclic thrombin receptor antagonists
11/30/2010CA2460682C Ester compound and medical use thereof
11/30/2010CA2456817C Alkyne-aryl-naphthyridin-4 (1h)-one derivatives as type iv phosphodiesterase inhibitor
11/30/2010CA2450076C Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or a diagnostic agent and pharmaceutical preparations containing said compounds
11/30/2010CA2440218C Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
11/30/2010CA2432809C Heteroaryl urea neuropeptide y y5 receptor antagonists
11/30/2010CA2396129C Method and formulation for treating resistance to antihypertensives and related conditions
11/30/2010CA2299295C Substituted tetrahydropyrane derivatives and method for producing same
11/30/2010CA2295876C Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/25/2010WO2010135541A2 Variants of c-type natriuretic peptide
11/25/2010WO2010135491A2 Fibroblast growth factor mutants having improved functional half-life and methods of their use
11/25/2010WO2010134799A1 Compositions comprising compounds from palm oil mill effluents for use in the prevention and treatment of cardiovascular diseases
11/25/2010WO2010134614A1 SELF-EMULSIFYING COMPOSITION OF ω3 FATTY ACID
11/25/2010WO2010134556A1 Aqueous injection solution containing 5-methyl-2-(1-piperazinyl)benzenesulfonic acid derivative
11/25/2010WO2010133815A1 Treatment of heart failure with normal ejection fraction
11/25/2010WO2010133672A1 Derivatives of quinoline-3-carboxylic acid and their medical use
11/25/2010WO2010133662A1 Use of il-17 polypeptides for use in the prevention or treatment of atherosclerosis
11/25/2010WO2010133647A1 Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors
11/25/2010WO2010133377A1 Fat blends and uses thereof
11/25/2010WO2010116380A3 A one pot process for preparing 2-butyl-3-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro [4, 4] non-1-en-4-one (irbesartan)
11/25/2010WO2010107991A3 Use of ixolaris, a tissue factor inhibitor, for the treatment and prevention of cancer
11/25/2010WO2010106436A3 Novel anti-inflammatory agents
11/25/2010WO2010089712A3 Formulation for the treatment of hypoxia and related disorders
11/25/2010WO2010085820A3 Tricyclic compounds as antagonists of prostaglandin d2 receptors
11/25/2010WO2010063995A3 Telmisartan with diuretic formulations
11/25/2010WO2009116848A8 Labisia pumila extracts for reducing the risk of cardiovascular diseases
11/25/2010US20100299766 Mouse models carrying a knock-out mutation of the qpctl-gene
11/25/2010US20100298769 Implantable medical devices for therapeutic agent delivery
11/25/2010US20100298561 2-amino-bicyclo(3.1.0) hexane-2, 6-dicarboxylic ester derivative
11/25/2010US20100298544 Cdr-grafted anti-tissue factor antibodies and methods of use thereof
11/25/2010US20100298427 Anti-inflammatory compositions and their use
11/25/2010US20100298408 Oligonucleotide Compositions with Enhanced Efficiency
11/25/2010US20100298400 Salts of perindopril
11/25/2010US20100298399 Endothelin Single Nucleotide Polymorphisms and Methods of Predicting B-Adrenergic Receptor Targeting Agent Efficacy
11/25/2010US20100298395 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
11/25/2010US20100298394 Antifungal agents as neuroprotectants
11/25/2010US20100298392 Isoindoline Derivatives For The Treatment Of Arrhythmias
11/25/2010US20100298370 Benzothiazolyl thienopyridine derivatives and uses thereof
11/25/2010US20100298368 Antagonists of pgd2 receptors
11/25/2010US20100298367 Conformationally Constrained Carboxylic Acid Derivatives Useful for Treating Metabolic Disorders
11/25/2010US20100298360 Small molecule inhibitors of pdz interactions
11/25/2010US20100298358 Naphthamide Derivatives As Multi-Target Protein Kinase Inhibitors and Histone Deacetylase Inhibitors
11/25/2010US20100298355 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
11/25/2010US20100298350 Triazolo[4,5-D]Pyrimidine Compounds For Treatment Of Abdominal Aortic Aneurysms
11/25/2010US20100298348 Method of Decreasing Ubiquitylated Protein Levels
11/25/2010US20100298344 Polycationic Compounds And Uses Thereof
11/25/2010US20100298337 Organic Compounds
11/25/2010US20100298333 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
11/25/2010US20100298332 Substituted Spirocyclic Piperidine Derivatives as Histamine-3 (H3) Receptor Ligands
11/25/2010US20100298330 Haloallylamine inhibitors of ssao/vap-1 and uses therefor
11/25/2010US20100298328 1-Heterocyclylamino-2-Hydroxy-3-Amino-Omega-Arylalkanes
11/25/2010US20100298322 Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use
11/25/2010US20100298316 Benzothiazoles Having Histamine H3 Receptor Activity
11/25/2010US20100298314 Novel jnk inhibitors
11/25/2010US20100298312 Substituted pyrimidinyl-amines as protein kinase inhibitors
11/25/2010US20100298310 Thiazole Derivatives as Kinase Inhibitors
11/25/2010US20100298307 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use
11/25/2010US20100298302 Novel protein kinase modulators
11/25/2010US20100298300 Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases
11/25/2010US20100298294 Ketone bodies and ketone body esters as blood lipid lowering agents
11/25/2010US20100298291 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/25/2010US20100298289 Heterobicyclic compounds as histamine h4-receptor antagonists
11/25/2010US20100298288 Cetp inhibitors derived from benzoxazole arylamides
11/25/2010US20100298286 Organic Compounds
11/25/2010US20100298285 Biclycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof
11/25/2010US20100298282 Treatment of Ocular Conditions and the Side-Effects of Glucocorticoids
11/25/2010US20100298278 Inhibitors of beta-secretase for the treatment of alzheimer's disease
11/25/2010US20100298277 Angiotensin ii receptor antagonists
11/25/2010US20100298269 Prodrugs of cgrp receptor antagonists
11/25/2010US20100298266 Hydroxyethylstarch
11/25/2010US20100298263 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
11/25/2010US20100298254 Organ arrest, protection and preservation
11/25/2010US20100298253 Pharmaceutical Compositions Comprising Forms of 5-Azacytidine
11/25/2010US20100298245 Pharmaceutical Composition for the Treatment of IL-8 mediated diseases
11/25/2010US20100298237 Use of hdac inhibitors for treatment of cardiac rhythm disorders
11/25/2010US20100298225 Peptide gap junction modulators
11/25/2010US20100298224 Use of mutated antithrombins for treating or preventing coagulation disorders
11/25/2010US20100298221 2-phenoxy nicotine acid derivative and use thereof
11/25/2010US20100298220 Fibroblast growth factor mutants having improved functional half-life and methods of their use
11/25/2010US20100298217 Csf-1r mutants
11/25/2010US20100298201 Peptidomimetic macrocycles with improved properties
11/25/2010US20100297270 Composition for treatment of ischemic heart disease, facilitation of blood circulation and angiogenesis, improving skin beauty, improving male sexual function containing ginseng berry extract
11/25/2010US20100297269 Compositions for intranasal administration
11/25/2010US20100297267 Compositions for diabetes treatment and prophylaxis
11/25/2010US20100297256 Methods and compositions for inhibiting integrins using tellurium-containing compounds
11/25/2010US20100297233 Oscillating cell culture bioreactor
11/25/2010US20100297227 Pharmaceutical composition comprising at least one active agent and a binder, which swells in an acidic media
11/25/2010US20100297219 Methods and Compositions for Modifying Apolipoprotein B mRNA Editing
11/25/2010US20100297196 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids
11/25/2010US20100297181 AMPA Receptor Antagonists for Epilepsy, Mental Disorders or Deficits in Sensory Organ
11/25/2010US20100297149 Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
11/25/2010US20100297129 Method for extending pregnancy in patients exhibiting at least one symptom of preeclampsia and eclampsia
11/25/2010US20100297107 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
11/25/2010US20100297105 Administering antisense oligonucleotides complementary to human apolipoprotein b
1 ... 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 ... 1595